COVID-19 Vaccine AstraZeneca: benefits still outweigh the risks despite possible link to rare blood clots with low blood platelets
EMAās safety committee, PRAC, concluded its preliminary review of a signal of blood clots in people…
EMAās safety committee, PRAC, concluded its preliminary review of a signal of blood clots in people…
La raccomandazione del Comitato di Valutazione dei rischi per la Farmacovigilanza (PRAC) dellāAgenzia Europea per…
Via libera dell'Agenzia europea del farmaco (Ema) al vaccino AstraZeneca. "Il vaccino AstraZeneca ĆØ sicuro,…